Kyowa Kirin Co., Ltd
Kyowa Kirin Co., Ltd., a specialty pharmaceutical company, engages in the research, development, manufacture, marketing, and import/export of pharmaceuticals in the therapeutic areas of oncology, nephrology, central nervous system, and immunology worldwide. Its products include ABSTRAL, a sublingual formulation of fentanyl used for the management of episodes of breakthrough pain experienced by cancer patients; ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; GRAN, a human colony-stimulating factor; and G-LASTA/Peglasta/Neulasta for chemotherapy-induced febrile neutropenia. The company's products also comprise LEUNASE for acute lymphoblastic leukemia; Mitomycin-C, an anticancer antibiotic; Moventig for the treatment of opioid induced constipation in adult patients; PecFent, a nasally administrated spray; POTELIGEO, a humanized monoclonal antibody that targets CC chemokine receptor 4; REGPARA, an agent for the treatment of secondary hyperparathyroidism; Romiplate/Nplate, a genetically recombinant protein, which stimulates platelet production through the stimulation of thrombopoietin receptors; and SANCUSO for the treatment for nausea and vomiting. Kyowa Kirin Co., Ltd. has a license, development, and commercialization agreement with MEI Pharma, Inc. The company was formerly known as Kyowa Hakko Kirin Co., Ltd. and changed its name to Kyowa Kirin Co., Ltd. in June 2019. The company was founded in 1949 and is headquartered in Tokyo, Japan. Kyowa Kirin Co., Ltd. operates as a subsidiary of Kirin Holdings Company, Limited. Show More...
-
Website http://www.kyowakirin.com
-
Sector Healthcare
-
Industry Drug Manufacturers-General
-
Last Quote 14.20 EUR
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share JPY 38.94 45.14 44.1 54.91 29.02 54.36 55.59 78.3 99.3 124.46 135.27 Dividends JPY 20.0 20.0 20.0 25.0 25.0 25.0 25.0 27.0 35.0 42.0 42.0 Payout Ratio % * 162.3 37.4 59.8 38.4 72.9 45.7 67.8 62.4 26.5 56.3 53.5 Shares Mil 570.0 567.0 549.0 548.0 548.0 548.0 548.0 548.0 539.0 548.0 549.0 Book Value Per Share * EUR 8.73 9.76 8.59 7.31 7.43 8.49 8.78 8.28 9.31 10.04 10.5 Free Cash Flow Per Share * EUR 0.32 0.52 0.49 0.15 0.08 0.23 0.64 0.66 0.57 0.27 Return on Assets % 3.19 3.78 3.62 4.3 2.21 4.14 2.63 6.1 7.5 8.79 9.62 Financial Leverage (Average) 1.28 1.22 1.22 1.21 1.19 1.17 1.16 1.15 1.14 1.16 1.15 Return on Equity % 4.11 4.73 4.42 5.23 2.65 4.88 3.07 7.05 8.6 10.1 11.21 Return on Invested Capital % 4.01 4.62 4.32 5.13 2.57 4.79 3.0 7.07 8.69 10.14 11.21 Interest Coverage 213.56 343.1 220.63 193.17 188.9 702.69 722.14 60.99 47.07 34.91 40.82 Current Ratio 2.82 3.63 3.54 3.87 3.32 3.82 4.11 4.44 4.8 5.13 5.38 Quick Ratio 2.04 2.67 2.58 2.73 2.01 2.64 2.95 3.31 3.76 4.52 4.69 Debt/Equity